Stocks
Health Care
vir
Vir Biotechnology
NASDAQ: VIR
+2.05 (+27.59%)
9.48
USD
At close at Feb 24, 21:43 UTC
Income Statement
Revenue
74.20M
Gross Profit
73.36M
Operating Income
-587.16M
Pretax Income
-499.39M
Net Income
-521.96M
EBITDA
-503.30M
EBIT
-523.11M
Earnings Per Share
-3.8200000000000003
Balance Sheet
Cash & Cash Equivalents
263.78M
Total Debt
96.93M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
1.34B
Book Value Per Share
9.85
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.